ROLE OF PRENATAL ULTRASONOGRAPHY IN WOMEN WITH POSITIVE SCREEN FOR DOWN-SYNDROME ON THE BASIS OF MATERNAL SERUM MARKERS

被引:71
|
作者
NYBERG, DA
LUTHY, DA
CHENG, EY
SHELEY, RC
RESTA, RG
WILLIAMS, MA
机构
[1] UNIV WASHINGTON,DEPT OBSTET & GYNECOL,SEATTLE,WA 98195
[2] SWEDISH MED CTR,MED CTR,CTR PERINATAL STUDIES,SEATTLE,WA
关键词
FETUS; CHROMOSOME ABNORMALITIES; PRENATAL ULTRASONOGRAPHY; PRENATAL DIAGNOSIS; DOWN SYNDROME; ALPHA-FETOPROTEIN; TRIPLE SCREEN;
D O I
10.1016/0002-9378(95)91322-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate the usefulness of prenatal ultrasonography among women with a positive screen for fetal Down syndrome on the basis of three biochemical markers - maternal serum ol-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. STUDY DESIGN: A total of 395 women underwent prenatal ultrasonography at a single institution after being identified as screen positive (midtrimester risk greater than or equal to 1:195) on the basis of triple-marker screening between 15 and 18 weeks. Ultrasonographic findings were compared with the biochemical markers and the eventual fetal outcome for these patients. Ultrasonographic abnormalities that were evaluated included structural defects, nuchal thickening or cystic hygroma, echogenic bowel, cerebral ventricular dilatation, pylectasis, and shortened femur. RESULTS: Among 395 patients, 374 (94.7%) had normal karyotype by genetic amniocentesis (n = 232) or postnatal follow-up (n = 142), 18 (4.5%) proved to have Down syndrome, and three had other karyotypic abnormalities. One or more ultrasonographic abnormalities were found in nine of 18 (50%) with Down syndrome compared to 27 of 377 (7.2%) other fetuses (p < 0.001). Fetuses with abnormal ultrasonography results included three with other chromosome abnormalities and five with nonchromosomal anomalies. An abnormal ultrasonography result increased the risk of Down syndrome by 5.6-fold (25% from 4.5%) and a negative result reduced the risk by 45% (2.5% from 4.5%). The value of ultrasonography is further enhanced when all chromosome abnormalities and nonchromosomal anomalies are considered. CONCLUSION: Abnormal ultrasonographic findings increase the risk for Down syndrome, whereas normal findings are less predictive of normalcy. After correction for inaccurate menstrual dates, genetic amniocentesis should be offered in spite of a normal ultrasonography result among women with positive triple screen.
引用
收藏
页码:1030 / 1035
页数:6
相关论文
共 50 条
  • [1] MATERNAL SERUM MARKERS AND PRENATAL SCREENING FOR DOWN-SYNDROME
    LEYMARIE, P
    LEPORRIER, N
    ARCHIVES FRANCAISES DE PEDIATRIE, 1993, 50 (05): : 455 - 457
  • [2] PRENATAL RISK INDEX FOR FETAL DOWN-SYNDROME BY SERUM MARKERS
    BARTELS, I
    SANCKEN, U
    ZEITSCHRIFT FUR GEBURTSHILFE UND PERINATOLOGIE, 1994, 198 (04): : 153 - 154
  • [3] A MATERNAL SERUM SCREEN FOR TRISOMY-18 - AN EXTENSION OF MATERNAL SERUM SCREENING FOR DOWN-SYNDROME
    STAPLES, AJ
    ROBERTSON, EF
    RANIERI, E
    RYALL, RG
    HAAN, EA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (05) : 1025 - 1033
  • [5] SONOGRAPHIC MARKERS IN PRENATAL SCREENING FOR DOWN-SYNDROME DETECTION
    VEROPOTVELYAN, NP
    VEROPOTVELYAN, PN
    KODUNOV, LA
    KOROTKOV, AV
    KHANE, IE
    PASTUSHENKO, AS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 178 - 178
  • [6] PRENATAL DETECTION OF X-LINKED ICHTHYOSIS BY MATERNAL SERUM SCREENING FOR DOWN-SYNDROME
    BARTELS, I
    CAESAR, J
    SANCKEN, U
    PRENATAL DIAGNOSIS, 1994, 14 (03) : 227 - 229
  • [7] Prenatal screening for Down's syndrome using maternal serum markers
    Dhondt, JL
    ANNALES DE BIOLOGIE CLINIQUE, 1998, 56 (04) : 471 - 475
  • [8] Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers
    Muller, F
    Thibaud, D
    Poloce, F
    Gelineau, MC
    Bernard, M
    Brochet, C
    Millet, C
    Réal, JY
    Dommergues, M
    PRENATAL DIAGNOSIS, 2002, 22 (11) : 1036 - 1039
  • [9] THE USE OF MATERNAL SERUM MARKERS FOR THE DETECTION OF DOWN-SYNDROME PREGNANCIES - SHOULD ESTRIOL BE INCLUDED
    DAVID, M
    DAR, H
    MERKSAMER, R
    ISRAEL, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 1395 - 1395
  • [10] DOWN-SYNDROME AND LOW MATERNAL SERUM ALPHA FETOPROTEIN
    JACOBS, S
    GILES, W
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1990, 30 (04): : 335 - 340